Omeros Corp (OMER)

7.43 -0.37  -4.74% NASDAQ Nov 26, 16:00 USD
View Full Chart
Price Chart
View All OMER News

News

View All Events

Events

Date Type Description
03/01/2022 Earnings Results Q4 2021 Earnings Results
03/01/2022 16:30 EST Earnings Calls Q4 2021 Earnings Call
11/09/2021 Earnings Results Q3 2021 Earnings Results
11/09/2021 16:30 EST Earnings Calls Q3 2021 Earnings Call
08/09/2021 Earnings Results Q2 2021 Earnings Results
08/09/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
06/11/2021 13:00 EST AGM 2020 Annual General Meeting
05/10/2021 Earnings Results Q1 2021 Earnings Results
05/10/2021 16:30 EST Earnings Calls Q1 2021 Earnings Call
03/01/2021 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Omeros Corp is a United States-based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injection), approved by the U.S. Food and Drug Administration and launched in the U.S. for use during cataract surgery and intraocular lens replacement. Its product pipeline is focused on complement-associated thrombotic microangiopathies; complement-mediated glomerulonephropathies; Huntington's disease and cognitive impairment; and addictive and compulsive disorders.
  • URL: https://www.omeros.com
  • Investor Relations URL: https://investor.omeros.com/
  • HQ State/Province: Washington
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Mar. 01, 2022
  • Last Earnings Release: Nov. 09, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
JMIGX Jacob Discovery Fd Instl 3.30%
JSCGX Jacob Small Cap Growth Investor 3.30%
JFWD Jacob Forward ETF 1.61%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.